Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Cash & Equivalents Growth (3y) (2013 - 2026)

Analysis

Acadia Pharmaceuticals (ACAD) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -1.21%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -9.15%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 6.56%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -11.22%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -4.76%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -25.80%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -17.71%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -28.16%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -15.41%
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 52.79%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.79%
Mar 31, 2026 -1.01%
Dec 31, 2025 15.66%
Sep 30, 2025 18.55%
Jun 30, 2025 21.96%
Mar 31, 2025 2.04%
Dec 31, 2024 29.42%
Sep 30, 2024 17.91%
Jun 30, 2024 -12.78%
Mar 31, 2024 -12.39%
Dec 31, 2023 -16.67%
Sep 30, 2023 -39.90%
Jun 30, 2023 -29.68%
Mar 31, 2023 18.90%
Dec 31, 2022 -15.40%
Sep 30, 2022 -26.22%
Jun 30, 2022 23.39%
Mar 31, 2022 28.07%
Dec 31, 2021 3.04%
Sep 30, 2021 13.99%
API Access

Acadia Pharmaceuticals Cash & Equivalents Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=ACAD&period=max&api_key=YOUR_API_KEY